$11.30
-0.27-2.33%
At close: -
$11.79
0.494.34%
After Hours: Feb 21, 5:20 PM EDT
Comments
Loading...
Benitec Biopharma (NASDAQ:BNTC) Stock, Earnings Estimates, EPS, And Revenue
Benitec Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.620
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Benitec Biopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Benitec Biopharma (BNTC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-02-14 | $-0.33 | $-0.58 | 43.1 % |
| Q1 | 2024-11-14 | $-0.48 | $-0.43 | -11.6 % |
| Q4 | 2024-09-26 | $-0.60 | $-0.43 | -39.5 % |
| Q3 | 2024-05-13 | $-1.64 | $-0.78 | -110.3 % |
Benitec Biopharma (BNTC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Benitec Biopharma (NASDAQ:BNTC) reporting earnings?
Benitec Biopharma (BNTC) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on February 14, 2025 for Q2.
What were the latest earnings per share (EPS) for Benitec Biopharma (NASDAQ:BNTC)?
The Actual EPS was $-0.33, which beat the estimate of $-0.58.
What were Benitec Biopharma’s (NASDAQ:BNTC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.